Flavopiridol treatment of patients aged 70 or older with refractory or relapsed chronic lymphocytic leukemia is a feasible and active therapeutic approach.
about
Flavopiridol can be safely administered using a pharmacologically derived schedule and demonstrates activity in relapsed and refractory non-Hodgkin's lymphoma.Mitochondrial priming of chronic lymphocytic leukemia patients associates Bcl-xL dependence with alvocidib response.Therapeutic advancement of chronic lymphocytic leukemia.A phase 1 clinical trial of flavopiridol consolidation in chronic lymphocytic leukemia patients following chemoimmunotherapyEmerging drug profile: cyclin-dependent kinase inhibitorsCyclophosphamide, alvocidib (flavopiridol), and rituximab, a novel feasible chemoimmunotherapy regimen for patients with high-risk chronic lymphocytic leukemiaHighlights of the Latest Advances in Research on CDK Inhibitors.Pharmacodynamic considerations of small molecule targeted therapy for treating B-cell malignancies in the elderly.Alvocidib (flavopiridol) for the treatment of chronic lymphocytic leukemia.
P2860
Q34114592-9CB0FDB7-66CD-4F66-AAFA-4D15D2C74383Q34458745-5250461C-3F41-4A25-AB7E-8F9FC37952AFQ36300303-236D5182-46DE-4617-92DB-A9D0C4D0127DQ37168430-42F071B4-93FA-46FE-875B-7B7B16C60B77Q37185372-8D81ED2C-93B1-4F16-9289-0B9AC5106ABFQ37602430-1C30A4B9-1370-4443-82C8-6863B7D13BA4Q38263222-01B5806F-5D9B-4C0F-B438-48A6AD4E8EA9Q38544216-2DF6B25D-15D2-45C8-9DEC-7B60A2008370Q38783064-05498763-B612-483D-B930-E22EE1059005
P2860
Flavopiridol treatment of patients aged 70 or older with refractory or relapsed chronic lymphocytic leukemia is a feasible and active therapeutic approach.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Flavopiridol treatment of pati ...... d active therapeutic approach.
@ast
Flavopiridol treatment of pati ...... d active therapeutic approach.
@en
type
label
Flavopiridol treatment of pati ...... d active therapeutic approach.
@ast
Flavopiridol treatment of pati ...... d active therapeutic approach.
@en
prefLabel
Flavopiridol treatment of pati ...... d active therapeutic approach.
@ast
Flavopiridol treatment of pati ...... d active therapeutic approach.
@en
P2093
P2860
P1433
P1476
Flavopiridol treatment of pati ...... d active therapeutic approach.
@en
P2093
Amy J Johnson
Amy S Ruppert
Deborah M Stephens
Jeffrey Jones
Joseph M Flynn
Kristie Blum
Michael R Grever
Mitch A Phelps
P2860
P304
P356
10.3324/HAEMATOL.2011.047324
P50
P577
2012-01-22T00:00:00Z